Pure Global

"100 first" insulin growth factor type 1 radioimmunoassay reagent - Taiwan Registration 630bd1b44efa2fb3f454fddc5809a2c0

Access comprehensive regulatory information for "100 first" insulin growth factor type 1 radioimmunoassay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 630bd1b44efa2fb3f454fddc5809a2c0 and manufactured by DIASOURCE IMMUNOASSAYS S.A.. The authorized representative in Taiwan is TAIWAN LIFE SUPPORT SYSTEMS INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
630bd1b44efa2fb3f454fddc5809a2c0
Registration Details
Taiwan FDA Registration: 630bd1b44efa2fb3f454fddc5809a2c0
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"100 first" insulin growth factor type 1 radioimmunoassay reagent
TW: โ€œ็™พ้ฆ–โ€้กž่ƒฐๅณถ็ด ็”Ÿ้•ทๅ› ๅญ็ฌฌไธ€ๅž‹ๆ”พๅฐ„ๅ…็–ซๅˆ†ๆž่ฉฆๅŠ‘
Risk Class 2

Registration Details

630bd1b44efa2fb3f454fddc5809a2c0

DHAS0602192804

Company Information

Belgium

Product Details

Insulin growth factor type 1 radioimmunoassay reagent for in vitro quantitative detection of human serum

A Clinical chemistry and clinical toxicology

A.1370 Human Growth Hormone Testing System

import

Dates and Status

Dec 16, 2010

Dec 16, 2025